The Acute Management of Intracerebral Hemorrhage
- 1 May 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 110 (5), 1419-1427
- https://doi.org/10.1213/ane.0b013e3181d568c8
Abstract
Intracerebral hemorrhage (ICH) is a devastating disease with high rates of mortality and morbidity. The major risk factors for ICH include chronic arterial hypertension and oral anticoagulation. After the initial hemorrhage, hematoma expansion and perihematoma edema result in secondary brain damage and worsened outcome. A rapid onset of focal neurological deficit with clinical signs of increased intracranial pressure is strongly suggestive of a diagnosis of ICH, although cranial imaging is required to differentiate it from ischemic stroke. ICH is a medical emergency and initial management should focus on urgent stabilization of cardiorespiratory variables and treatment of intracranial complications. More than 90% of patients present with acute hypertension, and there is some evidence that acute arterial blood pressure reduction is safe and associated with slowed hematoma growth and reduced risk of early neurological deterioration. However, early optimism that outcome might be improved by the early administration of recombinant factor VIIa (rFVIIa) has not been substantiated by a large phase III study. ICH is the most feared complication of warfarin anticoagulation, and the need to arrest intracranial bleeding outweighs all other considerations. Treatment options for warfarin reversal include vitamin K, fresh frozen plasma, prothrombin complex concentrates, and rFVIIa. There is no evidence to guide the specific management of antiplatelet therapy-related ICH. With the exceptions of placement of a ventricular drain in patients with hydrocephalus and evacuation of a large posterior fossa hematoma, the timing and nature of other neurosurgical interventions is also controversial. There is substantial evidence that management of patients with ICH in a specialist neurointensive care unit, where treatment is directed toward monitoring and managing cardiorespiratory variables and intracranial pressure, is associated with improved outcomes. Attention must be given to fluid and glycemic management, minimizing the risk of ventilator-acquired pneumonia, fever control, provision of enteral nutrition, and thromboembolic prophylaxis. There is an increasing awareness that aggressive management in the acute phase can translate into improved outcomes after ICH.Keywords
This publication has 87 references indexed in Scilit:
- Warfarin use leads to larger intracerebral hematomasNeurology, 2008
- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in AdultsStroke, 2007
- Death and Disability from Warfarin-Associated Intracranial and Extracranial HemorrhagesAmerican Journal Of Medicine, 2007
- Prevalence of elevated blood pressure in 563704 adult patients with stroke presenting to the ED in the United StatesThe American Journal of Emergency Medicine, 2007
- Meta analyses in treatment of spontaneous supratentorial intracerebral haematomaActa Neurochirurgica, 2006
- High Blood Pressure in Acute Stroke and Subsequent OutcomeHypertension, 2004
- Risk Factors for Intracerebral Hemorrhage in the General PopulationStroke, 2003
- Can Patients Be Anticoagulated After Intracerebral Hemorrhage?Stroke, 2003
- Perilesional Blood Flow and Edema Formation in Acute Intracerebral HemorrhageStroke, 1998
- Three Important Subgroups of Hypertensive Persons at Greater Risk of Intracerebral HemorrhageHypertension, 1998